Effect of Patola-Nimbadi Basti in the Management of Psoriasis w.s.r. to Ekakushtha

Phase 2

• Conditions: Health Condition 1: L409- Psoriasis, unspecified

• Registration Number: CTRI/2024/06/069477
• Lead Sponsor: Institute for Ayurved Studies and Research Umri Road Kurukshetra Haryana

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Subjects presenting with clinical features of Psoriasis.

2. Patients suffering from psoriasis with less than 50% of the body surface involvement.

3. Subjects with chronicity of disease more than 6 months and less than 5 yrs.

4. The patient who is fit for Basti Karma (Basti Yogya).

Exclusion Criteria

1. Patient presenting with clinical features other than psoriasis like generalized skin

lesions, herpes simplex, herpes zooster, scabies, acne, urticaria and immunological

medicated skin diseases like pemphigus vulgaris, dermatitis herpetiformis, guttate

psoriasis, pustular psoriasis, lupus erythematous, psoriatic arthropathy etc.

2. Patient suffering from severe psoriasis with more than 50% of the body surface

involvement.

3. Patient with chronicity of disease less than 6 months and above 5 yrs.

4. Subjects of either sex age below 20 years and above 60 years.

5. Patient on medication like corticosteroids, phototherapy, biologics, antidepressant

and any other drugs that may have an influence on the outcome of the study .

6. Alcoholics or drug abusers.

7. Systemic Lupus Erythematous and other Auto Immune disorders.

8. Patients having systematic pathologies like cardiac diseases, renal diseases and

endocrine disorders.

9. Pregnant and lactating women.

10. Patient who are contra-indicated for Basti Karma (Basti Ayogya).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relieve in the sign and symptoms of PsoriasisTimepoint: 45th day after treatment.

Secondary Outcome Measures

Name	Time	Method
1. To improve quality of life of patient. <br/ ><br>2. Remove the stress factor of Psoriasis patient. <br/ ><br>Timepoint: At 15th, 30th, 45th day after treatment.